Search

everythinglearnresearchcommunity

for

Search:↓

Different genes are active in dogs' hair growth and skin, similar to humans, which helps understand dog skin and hair diseases and can relate to human conditions.

Too much epidermal growth factor can cause hair loss.

Dental care may help improve hair loss in alopecia patients.

Combining hyperthermia with natural compounds and conventional treatments improves cancer therapy effectiveness and reduces side effects.

Extracellular vesicles show promise for medical use but face challenges in standardization and safety.

The guideline recommends personalized treatment for alopecia areata, including new oral medications and psychological support.

New treatments are needed for non-scarring alopecia due to current limitations.

Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.

Adipose tissue-derived exosomes may help regrow hair in alopecia areata.

Certain IL-18 gene variations may increase the risk of alopecia areata.

JAK inhibitors can effectively reverse hair loss in people with alopecia areata.

Tyrosinase and gp100 proteins can help diagnose and treat melanoma.

The role of antibodies in alopecia is unclear, but JAK inhibitors show promise for treatment.

Isotretinoin effectively treated a rare scalp condition, but careful drug monitoring and a dairy-free diet were important.

Cannabinoids may help treat various skin conditions.

Platelet-rich plasma therapy improves oral lichen planus symptoms with few side effects.

TNFα, IFNγ, and Substance P significantly affect prolactin levels in human skin, suggesting new treatments for skin and hair conditions.

Genetic discoveries are leading to new treatments for alopecia areata.

High mTORC1 activity slows hair growth and causes it to lose color.

Patients with severe active alopecia areata have lower CD200 expression and an imbalance in their immune system.

Microorganism overgrowth and hyperkeratosis may trigger immune reactions causing lichen planopilaris.

Researchers identified five new potential targets for leishmaniasis treatment, suggesting repurposing existing drugs could be effective.

Thyroid issues can cause alopecia areata.

Skin side effects from CDK4/6 inhibitors in breast cancer patients are generally mild and treatable, allowing most patients to continue treatment.

Enzymes are classified into six types and are essential for many biological processes, with only a few targeted by drugs.

Deucravacitinib may help treat various immune diseases beyond psoriasis, but more research is needed.

MJ04, a new compound, effectively promotes hair growth and is a potential topical treatment for hair loss.

Alopecia Areata is linked to specific gut bacteria and metabolites, indicating a complex gut microbiome.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

Experts recommend personalized treatment plans for best outcomes in managing Alopecia Areata.